# clm_D7E9283EA9D1

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: quarterly_net_income  
value: 1,217,400,000 United States dollar  
valid_from: 2018-03-31  
valid_to: 2018-06-30  
published: 2018-04-27  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_38DEDDCE8663  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company quarterly net income: 1,217,400,000 United States dollar", as of 2018-03-31 (until 2018-06-30). Claim clm_D7E9283EA9D1, https://asof.is/claim/clm_D7E9283EA9D1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947818000136/0000059478-18-000136-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q1 FY2018, filed 2018-04-27  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947818000136/0000059478-18-000136-index.htm (primary, SEC EDGAR 10-Q Q1 FY2018, published 2018-04-27)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_net_income | 555,600,000 United States dollar | valid 2017-09-30 to 2018-03-31 | conf 0.95 | superseded | superseded_by [clm_D7E9283EA9D1](/claim/clm_D7E9283EA9D1.md) | [clm_F933C58020E5](/claim/clm_F933C58020E5.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.